Answers are grounded in this paper and cite their sources.
Cardiovascular–kidney–metabolic (CKM) syndrome describes a multisystem continuum in which metabolic dysfunction, chronic kidney disease, and cardiovascular disease reinforce one another. Metabolic dysfunction-associated steatotic liver disease (MASLD) is common across CKM stages, but the mechanisms linking hepatic lipid handling to systemic injury remain unresolved. Hepatic metabolism depends on dynamic contacts among the endoplasmic reticulum, lipid droplets, and mitochondria, which coordinate lipid synthesis, storage, mobilization, oxidation, calcium handling, and organelle function. This review evaluates evidence that remodeling of these contacts contributes to MASLD and may amplify CKM crosstalk. We distinguish structural proximity from molecular composition and metabolic flux and propose operational criteria for a candidate “contact trap”: preserved or increased lipid droplet–mitochondria proximity accompanied by impaired adjustment of lipid droplet-derived fatty-acid handling to changing demand. This definition separates potentially maladaptive contact states from protective lipid storage and requires interface-selective perturbation and rescue to establish causality. We further examine evidence linking hepatic stress to circulating lipids, extracellular vesicles, mitochondrial danger signals, and inflammatory mediators while emphasizing that the liver is a potential metabolic amplifier rather than the sole initiator of multi-organ injury. Finally, we outline experimental and translational priorities for testing contact-dependent mechanisms, biomarkers, and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: